Abstract |
To measure the evolution of the serum levels of specific Osteoarthritis (OA) biomarker, Coll2-1 and Coll2-1 NO₂ in knee osteoarthritic patients after viscosupplementation (VS). Fifty-one patients with unilateral symptomatic knee were recruited for this prospective open label study. They received three intra-articular injections of 2 ml of hyaluronic acid (Hylan GF-20) and were followed for 3 months. Walking pain was evaluated and serum samples were taken at each visit. Coll2-1 and Coll2-1 NO₂ were measured in the serum using specific immunoassays. Variations over time of each parameter and predictive factor of response were studied. Forty-five patients were analyzed. The serum concentrations of Coll2-1 and Coll2-1 NO₂ were significantly higher in KL III/IV patients compared to KL I/II patients at baseline and decreased systematically over time after VS. Its effect was ever more pronounced in patients with KL III/IV. The serum concentration of Coll2-1 was significantly lower at baseline in responders than in non-responders. This study suggests a rapid slowdown of type II collagen degradation and joint inflammation after VS with Hylan G-20 and gives additional information for the validation of accurate biomarkers for OA. The serum level of Coll2-1 appeared to be a predictive factor for response to treatment.
|
Authors | Y Henrotin, X Chevalier, M Deberg, J C Balblanc, P Richette, D Mulleman, B Maillet, F Rannou, C Piroth, P Mathieu, T Conrozier, Osteoarthritis Group of French Society of Rheumatology |
Journal | Journal of orthopaedic research : official publication of the Orthopaedic Research Society
(J Orthop Res)
Vol. 31
Issue 6
Pg. 901-7
(Jun 2013)
ISSN: 1554-527X [Electronic] United States |
PMID | 23423846
(Publication Type: Clinical Trial, Journal Article, Multicenter Study)
|
Copyright | Copyright © 2013 Orthopaedic Research Society. |
Chemical References |
- Biomarkers
- Collagen Type II
- Peptide Fragments
- Viscosupplements
- collagen type II (108-116)
- collagen type II (108-116), (NO2)Tyr(111)-
- Hyaluronic Acid
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Biomarkers
(blood)
- Collagen Type II
(blood)
- Female
- Humans
- Hyaluronic Acid
(administration & dosage)
- Injections, Intra-Articular
- Male
- Middle Aged
- Osteoarthritis, Knee
(blood, drug therapy)
- Peptide Fragments
(blood)
- Prospective Studies
- Viscosupplements
(administration & dosage)
|